"Progesterone Congeners" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.
| Descriptor ID |
D045167
|
| MeSH Number(s) |
D06.472.334.851.687
|
| Concept/Terms |
Progestational Hormones, Synthetic- Progestational Hormones, Synthetic
- Synthetic Progestational Hormones
- Progestin Analogs
- Progestogens, Synthetic
- Synthetic Progestogens
- Progestins, Synthetic
- Progestational Hormone Analogues
- Progestin Analogues
- Progestagens, Synthetic
- Synthetic Progestagens
- Progestational Hormone Analogs
- Synthetic Progestins
|
Below are MeSH descriptors whose meaning is more general than "Progesterone Congeners".
Below are MeSH descriptors whose meaning is more specific than "Progesterone Congeners".
This graph shows the total number of publications written about "Progesterone Congeners" by people in this website by year, and whether "Progesterone Congeners" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1997 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Progesterone Congeners" by people in Profiles.
-
17-alpha-hydroxyprogesterone caproate for maintenance tocolysis: a systematic review and metaanalysis of randomized trials. Am J Obstet Gynecol. 2015 Jul; 213(1):16-22.
-
17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model. Hypertension. 2015 Jan; 65(1):225-31.
-
Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study. Cancer Res. 2014 Dec 01; 74(23):7060-8.
-
The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women. Menopause. 2010 May-Jun; 17(3):622-9.
-
Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. Obstet Gynecol. 2010 Feb; 115(2 Pt 1):234-242.
-
A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007 Aug 02; 357(5):454-61.
-
The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol. 2007 Feb; 21(2):359-75.
-
Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception. 2005 May; 71(5):319-26.
-
p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells. J Steroid Biochem Mol Biol. 2005 Feb; 93(2-5):173-82.
-
5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators. J Med Chem. 2003 Sep 11; 46(19):4104-12.